insights_auto
Why is BOT down 11,11%?
Dive Deeperchevron_right
BOT:ASX
Botanix Pharmaceuticals Ltd
0,0080 AUD
arrow_downward
-11,11%(-0,00100) 1D
16-ноя., 16:10:15 GMT+11 · AUD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for BOT...
Open
0,01 AUD
High
0,01 AUD
Low
0,01 AUD
Mkt. cap
19,89 млн
Avg. vol.
9,99 млн
Volume
30,19 млн
52-wk high
0,15 AUD
52-wk low
0,01 AUD
EPS
-0,03 AUD
Shares outstanding
2,76 млд
No. of employees
11
Open
0,01 AUD
High
0,01 AUD
Low
0,01 AUD
Mkt. cap
19,89 млн
Avg. vol.
9,99 млн
Volume
30,19 млн
52-wk high
0,15 AUD
52-wk low
0,01 AUD
EPS
-0,03 AUD
Shares outstanding
2,76 млд
No. of employees
11
News stories
From web sources and news partners
24/7 Wall St.
·
26 мүнөт мурун
S&P 500 Closes Down 2% as Nasdaq Leads Broad Market Lower
The Motley Fool
·
1 саат мурун
Here's How the S&P 500 Has Moved the Day After Each of Nvidia's Last 12 Reports
ChartMill
·
1 саат мурун
S&P 500 Top Movers: Gainers and Losers for Nov. 16, 2026
The Korea Times
·
3 саат мурун
Wall Street slumps on AI jitters ahead of Nvidia results, Anthropic IPO
Profile
Botanix Pharmaceuticals is listed on the Australian Securities Exchange with the issue code BOT. The Company is headquartered in Perth, Western Australia and Philadelphia, USA. It is a clinical stage synthetic cannabinoid company, focusing on the compound Cannabidiol. The company's lead product is Sofdra, which treats axillary hyperhidrosis. The company has two separate development platforms, dermatology and antimicrobial. Botanix also has an exclusive license to use a proprietary drug delivery system Permetrex, for direct skin delivery of active pharmaceuticals which is utilised in all of their programs. Wikipedia
About Botanix Pharmaceuticals Ltd
CEO-
Employees11
Founded1984
Headquarters-
SectorHealth Care
IndustryPharmaceutical industry
Websitebotanixpharma.com